FLEXBUMIN SIDE EFFECTS
- Generic Name: albumin (human) usp, 5% solution
- Brand Name: Flexbumin
- Drug Class: Volume Expanders
Last updated on MDtodate: 10/04/2022
The most serious adverse reactions are hypersensitivity reaction (including anaphylactic reaction) and pulmonary edema.
Clinical Trials Experience
No sponsor initiated clinical studies have been conducted with FLEXBUMIN 5%.
The following adverse reactions have been identified during post-approval use of FLEXBUMIN 5%. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
The following adverse reactions have been reported in the post approval use of FLEXBUMIN 5%:
- Immune System Disorders: Anaphylactic shock, anaphylactic reaction, hypersensitivity/allergic reactions
- Nervous System Disorders: Headache, dysgeusia
- Cardiac Disorders: Myocardial infarction, atrial fibrillation, tachycardia
- Vascular Disorders: Hypotension, flushing
- Respiratory, Thoracic, and Mediastinal Disorders: Pulmonary edema, dyspnea
- Gastrointestinal Disorders: Vomiting, nausea
- Skin and Subcutaneous Tissue Disorders: Urticaria, rash, pruritus
- General Disorders and Administration Site Conditions: Pyrexia, chills
SRC: NLM .